Delivery Order SPE2DB24D2212-SPE2DB25FHNBB
Award Date
10/24/24
Potential Completion Date
10/25/24
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,544.11, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets. This is a firm-fixed-price delivery order contract with a performance period extending to May 29, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $6,190.25 and is for the delivery of Losartan-HCTZ 100-12.5 mg tablets. It is a Firm Fixed Price Delivery Order contract that runs through January 13, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,333.04 firm-fixed price delivery order is for 4,564,956,350 units of the medication Losartan-HCTZ 100-12.5 mg tablets. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,178,710 units of the generic drug Losartan-HCTZ 100-25 mg tablets in 90-count bottles. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,009.44 and a completion date of October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,403.12, is for the delivery of 4566450300 - LOSARTAN-HCTZ 100-25 MG TAB 90S, a cardiovascular medication, with a completion date of November 18, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for 50/12.5 mg losartan-HCTZ tablets. The $31,460.64 firm fixed price delivery order contract has a completion date of May 9, 2024 and is not set aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 for a broad range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count bottles. The $1,519.28 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 20, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Losartan-HCTZ 100-12.5 mg tablets. The $9,498.61 firm fixed-price delivery order was issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award, valued at $2,605.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order, is for the supply of 4565911704 - Losartan-HCTZ 50-12.5 mg tablets. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,486.20, is a delivery order for Losartan-HCTZ 100-12.5 mg tablets. The contract has an ultimate completion date of July 16, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...